Scott B. Brown, Chief Financial Officer at Tracon Pharmaceuticals, Inc. (TCON), bought 1,000 shares at $8.30 ($8K) on 2021-03-08, disclosed to the SEC on 2021-03-09.
Open-market purchase of $8k TCON by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TCON | BUY | 2022-03-30 | $3K | — | Filing → |
| TCON | BUY | 2021-08-17 | $4K | — | Filing → |